Cervical Dysplasia

This is a specific type of cervix problem where the cells in the very bottom layer of the cervix are changing and look abnormal. Think of it like a pre-cancerous condition, meaning it could potentially develop into cancer if not treated. It's often called 'CIN' for short.

Condition

What people with Cervical Dysplasia report

Every report comes from a Lived member, sent anonymously.

Have you had LEEP for Cervical Dysplasia?

NameHow it went

About Cervical Dysplasia

What It Is

Cervical dysplasia means that cells on the surface of the cervix, the lower end of the uterus that opens into the vagina, have started to grow and look abnormal. It is not cancer. It is a precancerous change: mild changes often return to normal on their own, while more severe changes can turn into cervical cancer over several years if they are not found and treated. Dysplasia usually causes no symptoms, so it is almost always discovered through routine cervical cancer screening with a Pap test, a test for human papillomavirus (HPV) or both. This is why screening works so well: finding and treating these changes early is one of the main ways cervical cancer is prevented. On a biopsy, dysplasia is called cervical intraepithelial neoplasia (CIN), meaning abnormal growth confined to the surface layer of the cervix. It is graded from 1 to 3. CIN 1 is mild, CIN 2 is moderate and CIN 3 is severe. The grade does more than anything else to decide what happens next.

Causes & Risk Factors

Nearly all cervical dysplasia is caused by a long-lasting infection with a high-risk type of HPV, a very common virus passed through close skin-to-skin contact, usually during sex. Most sexually active people get HPV at some point, and the immune system usually clears it within a year or two without lasting harm. Dysplasia develops when a high-risk infection persists for years and gradually changes the cervical cells. Two types, HPV 16 and HPV 18, cause most cervical cancers. Some factors make HPV more likely to persist or to cause more serious changes. A weakened immune system, from human immunodeficiency virus (HIV) infection or from medicines taken after an organ transplant or for an autoimmune disease, is one of the most important. Smoking, and regular exposure to secondhand smoke, also raises the risk. Starting sex at a young age and having more partners increase the chance of picking up high-risk HPV in the first place. A rare additional factor is exposure before birth to diethylstilbestrol (DES), a hormone drug some pregnant women were given between 1940 and 1971. HPV vaccination protects against the virus types most likely to cause dysplasia and cancer. It works best when given before any exposure to HPV, which is why it is routinely offered at age 11 or 12. It does not treat an infection someone already has, so vaccinated people still need regular screening.

How It's Diagnosed

Dysplasia is usually suspected after a screening test. An HPV test looks for high-risk HPV in a sample of cervical cells, and a Pap test (also called cytology) looks at the cells themselves under a microscope. Pap results use their own terms. LSIL (low-grade squamous intraepithelial lesion) suggests mild changes, usually from an HPV infection that often goes away. HSIL (high-grade squamous intraepithelial lesion) suggests moderate or severe changes that are more likely to need treatment. ASC-US (atypical squamous cells of undetermined significance), the most common abnormal result, means some cells look slightly unusual for reasons that are not yet clear. AGC (atypical glandular cells) means abnormal-looking glandular cells, a less common finding that always needs a closer look. A screening result is not a diagnosis on its own. US guidelines from the American Society for Colposcopy and Cervical Pathology (ASCCP) estimate each person's risk from the current result together with past results, any previous treatment and factors such as age and immune health. Depending on that risk, the next step may be a repeat test in one or three years, a colposcopy, or, when the risk is very high, treatment without waiting for a biopsy. A colposcopy is done in the office much like a Pap test. The clinician applies a vinegar solution that makes abnormal areas stand out and examines the cervix through a magnifying instrument with a light. Small biopsies are taken from any suspicious areas, which usually feels like a pinch or a cramp, and cells may also be sampled from inside the cervical canal. The biopsy provides the CIN grade that guides treatment.

Treatment Options

Treatment depends mainly on the grade, on age and on plans for pregnancy. The aim is to remove or destroy abnormal cells before they can become cancer, without putting people through procedures they do not need. CIN 1 usually clears as the immune system controls HPV, so it is generally watched with repeat testing rather than treated, even when it lasts a couple of years. CIN 3 is a direct forerunner of cancer, and treatment is recommended at any age, with pregnancy as the main exception. CIN 2 sits between them. About half of CIN 2 lesions go away without treatment, but roughly one in five progresses to CIN 3 or worse, so treatment is usually recommended for people 25 or older. Close observation, with colposcopy and testing every six months, is an alternative for people under 25, in whom CIN 2 often resolves and cancer is rare, and for people whose concern about a future pregnancy outweighs their concern about cancer. If CIN 2 is still present after two years, treatment is recommended. The most common treatment is the loop electrosurgical excision procedure (LEEP), in which a thin wire loop carrying an electric current removes a shallow layer of the cervix containing the abnormal area. It is usually done in the office with a local anesthetic and takes a few minutes. Because the tissue goes to a lab, it confirms the grade and shows whether the abnormal area was fully removed. A cold knife cone biopsy removes a similar cone-shaped piece with a scalpel and is done in a hospital under general anesthesia. Ablation destroys the abnormal tissue in place instead, by freezing (cryotherapy), laser or heat. It leaves no tissue to examine, so it suits only lesions that are small and fully visible. Hysterectomy is not used as a first treatment for CIN alone. It is mainly used for adenocarcinoma in situ (a precancer of the glandular cells lining the cervical canal) or for high-grade dysplasia that returns when another excision is not possible. The main trade-off involves pregnancy. Excision can slightly raise the chance of a later premature birth, more so when more tissue is removed, although studies disagree about how large that effect is. Ablation appears to have little or no effect on pregnancy. During pregnancy itself, high-grade changes are usually monitored with colposcopy, and treatment is reconsidered after delivery unless cancer is suspected. For people aged 27 to 45 who have never had the HPV vaccine, the American College of Obstetricians and Gynecologists (ACOG) notes that getting it as part of treatment for CIN 2 or CIN 3 may help keep the changes from coming back.

What to Expect

With regular screening and follow-up, most cervical dysplasia either resolves or is treated successfully long before it could become cancer. Mild changes often take a year or two to clear, which can mean several rounds of repeat testing. The waiting can feel uncomfortable, but it reflects how often these changes go away without any procedure. After a colposcopy with biopsy, a day or two of cramping and a few days of spotting or dark discharge (from the medicine used to stop bleeding) are common. After LEEP, a watery pinkish or brownish-black discharge and mild cramping are expected, and the cervix takes a few weeks to heal. During healing, people are asked not to use tampons, douche or have sex until their clinician says it is safe. Treatment clears the abnormal area for most people, but dysplasia can return because HPV can persist. Follow-up therefore matters as much as the procedure itself. US guidelines recommend an HPV-based test six months after treatment, then yearly tests until three in a row are negative, then testing every three years for at least 25 years, continuing past age 65 if needed. That long timeline exists because people treated for high-grade changes keep about twice the usual risk of cervical cancer for decades. Not smoking removes one avoidable risk.

When to Seek Help

Keep every scheduled repeat test and colposcopy, and contact the clinic if you have missed one or are unsure when the next is due; delayed follow-up is one of the main ways a precancer that could have been treated is missed. Arrange an evaluation for bleeding after sex, between periods or after menopause, or for a persistent unusual discharge or pelvic pain. Screening tests are designed for people without symptoms, so these signs deserve their own assessment. After a biopsy, LEEP or other cervical treatment, call your gynecologist right away for heavy bleeding (more than one pad an hour, or heavier than a normal period), bleeding with clots, severe lower abdominal pain, or fever or chills.

Questions to Ask Your Doctor

  1. 1.What grade of dysplasia did my biopsy show, and how likely is it to go away on its own?
  2. 2.Is watching and retesting a reasonable choice for me, or do you recommend treatment now, and why?
  3. 3.If I may want to become pregnant later, how would treatment affect that, and which procedure would you suggest?
  4. 4.What follow-up schedule will I need, and what happens if a result is abnormal again?
  5. 5.Would the HPV vaccine help me at this point?

Last reviewed • Oct 2026

Educational content, not medical advice.